An integrated knowledge database dedicated to ncRNAs, especially lncRNAs.

Detail infomation of NONHSAG001627.1

General info


NONCODE GENE IDNONHSAG001627.1
Chromosomechr1
Start Site58838447
End Site59029886
Strand-
Length7503
Assemblyhg38
ClassLinc;
Other Gene VersionsNONHSAG001627.2(old version)

Transcripts in Gene


NONCODE TRANSCRIPT ID

Expression Profile (Data Source:Human Body Map)

adiposeadrenalbrainbrain_Rbreastcolonforeskinheart
heart_RHLF_1HLF_2kidneyliverliver_RlunglymphNode
ovaryplacenta_RprostateskeltalMuscletestestestes_RthyroidwhiteBloodCell
NA

Exosome Expression Profile (Data Source: NCBI GEO)

NA

Conservation Info


  • Chordata
    • Vertebrates
      • Manmals
        • Primates
          • Human
          • Chimp : N/A
          • Gorilla : N/A
          • Orangutan : N/A
          • Rhesus : N/A
        • Rodents
          • Mouse : N/A
          • Rat : N/A
        • Laurasiatheria
          • Pig : N/A
          • Cow : N/A
        • Opossum : N/A
        • Platypus : N/A
      • Birds
        • Chicken : N/A
    • Actinopteryqii
      • Zebrafish : N/A

Note: T = There are transcripts in this region.


Disease related

Disease:

NONCODE IDGene SymbolDisease nameSource DatabaseSource PMID

Mutations:

NONCODE IDSNP IDGWAS traitSource PMID
NONHSAG001627.3rs942123Autism20663923
NONHSAG001627.3rs942124Serum ratio of (1-methylxanthine)/(DSGEGDFXAEGGGVR*)21886157
NONHSAG001627.3rs2984911Gene expression of TACSTD2 in peripheral blood monocytes20502693
NONHSAG001627.3rs2984911Serum ratio of (hexadecanedioate)/(piperine)21886157
NONHSAG001627.3rs17356414Serum ratio of (erythronate*)/(gamma-glutamylvaline)21886157
NONHSAG001627.3rs17356414Type 2 diabetes17463248
NONHSAG001627.3rs9436174Major depressive disorder22472876
NONHSAG001627.3rs9436174Serum ratio of (lathosterol)/(pyroglutamylglycine)21886157
NONHSAG001627.3rs4601609Cognitive performance19734545
NONHSAG001627.3rs4601609Pattern recognition memory19734545
NONHSAG001627.3rs6676059Type 2 diabetes17463248
NONHSAG001627.3rs12140615Serum ratio of (4-hydroxyphenylacetate)/(stachydrine)21886157
NONHSAG001627.3rs12133457Type 2 diabetes17463248
NONHSAG001627.3rs12133457Serum ratio of (cysteine-glutathione disulfide)/(decanoylcarnitine)21886157
NONHSAG001627.3rs6679571Serum ratio of (erythronate*)/(N-acetylthreonine)21886157
NONHSAG001627.3rs6679571Fasting blood glucose20081858
NONHSAG001627.3rs17118349Alcohol dependence20201924
NONHSAG001627.3rs2492321Serum ratio of (10-undecenoate (11:1n1))/(2-palmitoylglycerophosphocholine*)21886157
NONHSAG001627.3rs11207323Serum ratio of (deoxycholate)/(lathosterol)21886157
NONHSAG001627.3rs6661505Gene expression of FAM62A in peripheral blood monocytes20502693
NONHSAG001627.3rs6661505Gene expression of RPS29 in peripheral blood monocytes20502693
NONHSAG001627.3rs6661505Irritible bowel syndrome18587394
NONHSAG001627.3rs6661505Serum concentration of arabitol21886157
NONHSAG001627.3rs11207324Serum ratio of (catechol sulfate)/(gamma-glutamylisoleucine*)21886157
NONHSAG001627.3rs12401645Serum ratio of (dodecanedioate)/(glycylvaline)21886157
NONHSAG001627.3rs2011623Serum ratio of (gamma-glutamylglutamate)/(pyridoxate)21886157
NONHSAG001627.3rs3015311Serum ratio of (3-hydroxy-2-ethylpropionate)/(tiglyl carnitine)21886157
NONHSAG001627.3rs11207325Gene expression of FAM62A in peripheral blood monocytes20502693
NONHSAG001627.3rs11207325Serum ratio of (alpha-hydroxyisovalerate)/(N-(2-furoyl)glycine)21886157
NONHSAG001627.3rs927743Schizophrenia19197363
NONHSAG001627.3rs927743Serum concentration of linoleamide (18:2n6)21886157
NONHSAG001627.3rs927743Serum concentration of beta-hydroxyisovalerate21886157
NONHSAG001627.3rs2716105Serum ratio of (3-hydroxy-2-ethylpropionate)/(laurylcarnitine)21886157
NONHSAG001627.3rs4912380Serum ratio of (n-Butyl Oleate)/(paraxanthine)21886157
NONHSAG001627.3rs17096897Serum ratio of (oleoylcarnitine)/(palmitoylcarnitine)21886157
NONHSAG001627.3rs11207332Serum ratio of (4-ethylphenylsulfate)/(gamma-glutamylthreonine*)21886157
NONHSAG001627.3rs2716115Serum ratio of (3-hydroxy-2-ethylpropionate)/(alpha-hydroxyisovalerate)21886157
NONHSAG001627.3rs2764914Serum concentration of beta-hydroxyisovalerate21886157
NONHSAG001627.3rs6667591Gene expression of CBX8 in peripheral blood monocytes20502693
NONHSAG001627.3rs6667591Serum concentration of leucylleucine21886157
NONHSAG001627.3rs6681035Serum ratio of (isoleucine)/(urate)21886157
NONHSAG001627.3rs7528731Gene expression of FAM62A in peripheral blood monocytes20502693
NONHSAG001627.3rs7528731Serum ratio of (3-hydroxy-2-ethylpropionate)/(oleoylcarnitine)21886157
NONHSAG001627.3rs6677752Serum ratio of (beta-hydroxyisovalerate)/(scyllo-inositol)21886157
NONHSAG001627.3rs2764928Coronary artery disease (CAD)23202125
NONHSAG001627.3rs2764928Gene expression of JUN in blood21829388
NONHSAG001627.3rs6699576Coronary artery disease (CAD), combined control dataset17554300
NONHSAG001627.3rs6699576Multiple complex diseases17554300
NONHSAG001627.3rs3949912Response to mTOR inhibitor (rapamycin)24009623
NONHSAG001627.3rs3949912Serum ratio of (cholate)/(glycocholate)21886157
NONHSAG001627.3rs7543260Response to mTOR inhibitor (everolimus)24009623
NONHSAG001627.3rs7543260Response to mTOR inhibitor (rapamycin)24009623
NONHSAG001627.3rs2764933Gene expression of JUN in blood21829388
NONHSAG001627.3rs2764933Serum ratio of (3-methoxytyrosine)/(pseudouridine)21886157
NONHSAG001627.3rs7537319PROP taste detection threshold22132133
NONHSAG001627.3rs11807036Alcohol dependence20201924
NONHSAG001627.3rs2764938Serum ratio of (tetradecanedioate)/(thromboxane B2)21886157
NONHSAG001627.3rs2764938Serum ratio of (3-methoxytyrosine)/(oleoylcarnitine)21886157
NONHSAG001627.3rs2985884Serum ratio of (gamma-tocopherol)/(levulinate (4-oxovalerate))21886157
NONHSAG001627.3rs2985883Fat mass17463246
NONHSAG001627.3rs2985883Serum ratio of (gamma-tocopherol)/(levulinate (4-oxovalerate))21886157
NONHSAG001627.3rs3010339Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs11207367Coronary artery disease (CAD)23202125
NONHSAG001627.3rs11207367Gene expression of JUN in blood21829388
NONHSAG001627.3rs2716139Serum ratio of (1-palmitoylglycerophosphoinositol*)/(1-stearoylglycerol (1-monostearin))21886157
NONHSAG001627.3rs2716139Type 2 diabetes17463246
NONHSAG001627.3rs2716139Fat mass17463246
NONHSAG001627.3rs12031587Height in Type 2 diabetes cases17463246
NONHSAG001627.3rs12031587Type 2 diabetes17463246
NONHSAG001627.3rs2716140Spatial working memory strategy19734545
NONHSAG001627.3rs2716140Fat mass17463246
NONHSAG001627.3rs2716140Type 2 diabetes17463246
NONHSAG001627.3rs2716140Serum ratio of (3-hydroxy-2-ethylpropionate)/(hexadecanedioate)21886157
NONHSAG001627.3rs2716140Serum ratio of (cysteine-glutathione disulfide)/(isobutyrylcarnitine)21886157
NONHSAG001627.3rs1812402Gene expression of JUN in blood21829388
NONHSAG001627.3rs1812402Spatial working memory strategy19734545
NONHSAG001627.3rs2716121Gene expression of JUN in blood21829388
NONHSAG001627.3rs2716121Spatial working memory strategy19734545
NONHSAG001627.3rs2716121Fat mass17463246
NONHSAG001627.3rs2716121Type 2 diabetes17463246
NONHSAG001627.3rs2716121Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs752281Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs751187Serum concentration of cysteine21886157
NONHSAG001627.3rs3010336Serum ratio of (1,3,7-trimethylurate)/(heme*)21886157
NONHSAG001627.3rs17464532Serum ratio of (1-methylxanthine)/(taurolithocholate 3-sulfate)21886157
NONHSAG001627.3rs17464532Type 1 diabetes, combined control dataset, gender differentiated17554300
NONHSAG001627.3rs17464532Multiple complex diseases17554300
NONHSAG001627.3rs2716133Fat mass17463246
NONHSAG001627.3rs2716133Type 2 diabetes17463246
NONHSAG001627.3rs2716133Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs12030196Height in Type 2 diabetes cases17463246
NONHSAG001627.3rs12030196Type 2 diabetes17463246
NONHSAG001627.3rs17118549Amyotrophic lateral sclerosis (ALS) (early age of onset)17671248
NONHSAG001627.3rs2764924Fat mass17463246
NONHSAG001627.3rs2764924Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs11207369Type 2 diabetes17463246
NONHSAG001627.3rs11207369Height in Type 2 diabetes cases17463246
NONHSAG001627.3rs2764922Type 2 diabetes17463246
NONHSAG001627.3rs2764922Fat mass17463246
NONHSAG001627.3rs2764922Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs2716136Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs2985887Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs3010334Type 2 diabetes17463246
NONHSAG001627.3rs3010334Fat mass17463246
NONHSAG001627.3rs3010334Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs1408954Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs12748496Height in Type 2 diabetes cases17463246
NONHSAG001627.3rs12748496Type 2 diabetes17463246
NONHSAG001627.3rs2716130Serum concentration of serotonin (5HT)21886157
NONHSAG001627.3rs9436591Fibrinogen17255346
NONHSAG001627.3rs9436591Variant Creutzfeldt-Jakob disease22210626
NONHSAG001627.3rs9436591Serum concentration of 2-oleoylglycerophosphocholine*21886157

Potential Function


NA